Banque de Luxembourg Investments (BLI)’s AbbVie ABBV Stock Holding History

Banque de Luxembourg Investments (BLI)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$316K	Hold	1,399	–	–	0.01%	164
2025 Q4	$321K	Sell	1,399 -5,100	-78%	-$1.16M	0.01%	167
2025 Q3	$1.45M	Sell	6,499 -3,500	-35%	-$713K	0.04%	154
2025 Q2	$1.82M	Sell	9,999 -1,800	-15%	-$335K	0.05%	162
2025 Q1	$2.42M	Sell	11,799 -1,200	-9%	-$233K	0.07%	115
2024 Q4	$2.29M	Buy	+12,999	New	+$2.39M	0.06%	116

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Banque de Luxembourg Investments (BLI)'s ABBV Position: Q1 2026 in Review

Banque de Luxembourg Investments (BLI) held its AbbVie (ABBV) position steady in Q1 2026 at 1,399 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #164.

Banque de Luxembourg Investments (BLI) first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.42M in Q1 2025. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Banque de Luxembourg Investments (BLI) held 1,399 shares of AbbVie worth $316K as of Q1 2026.
Banque de Luxembourg Investments (BLI) left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.01% of Banque de Luxembourg Investments (BLI)'s portfolio in Q1 2026, its #164 holding.
Banque de Luxembourg Investments (BLI) first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Banque de Luxembourg Investments (BLI)'s AbbVie position peaked at $2.42M in Q1 2025.
4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q1 2026, filed 15 May 2026.